RNAi modulation of MLL-AF4 and uses thereof

Details RNAi modulation of MLL-AF4 and uses thereof RNAi modulation of MLL-AF4 and uses thereof

2008-04-22

2008-04-22

Whiteman, Brian (Department: 1635)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

Reexamination Certificate

active

11303367

ABSTRACT:
The invention relates to compositions and methods for modulating the expression of the MLL-AF4 fusion gene, and more particularly to the downregulation of MLL-AF4 by chemically modified oligonucleotides.

REFERENCES:
patent: 4957735 (1990-09-01), Huang
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5043164 (1991-08-01), Huang et al.
patent: 5686101 (1997-11-01), Tagawa et al.
patent: 5705187 (1998-01-01), Unger
patent: 5817856 (1998-10-01), Tirosh et al.
patent: 5820873 (1998-10-01), Choi et al.
patent: 5853755 (1998-12-01), Foldvari
patent: 6107094 (2000-08-01), Crooke
patent: 2003/0175950 (2003-09-01), McSwiggen
patent: 2005/0107325 (2005-05-01), Manoharan et al.
patent: 2005/0245475 (2005-11-01), Khvorova et al.
patent: WO 2004/064737 (2004-08-01), None
patent: WO 2004/080406 (2004-09-01), None
patent: WO 2004/094345 (2004-11-01), None
patent: WO 2004/094595 (2004-11-01), None
T. Tuschl,□□Mammalian RNA interference: in RNAi, a guide to gene silencing, G. J. Hannon (ed.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2003, 265-295.
Allen et al., “Large unilamellar liposomes with low uptake into the reticuloendothelial system”FEBS Lett. 223:42-46 (1987).
Asou et al., “Establishment of a Human Acute Myeloid Leukemia Cell Line (Kasumi-1) With 8;21 Chromosome Translocation”Blood77:2031-2036 (1991).
Ayton et al., “Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins”Oncogene20:5695-5707 (2001).
Banerjee et al., “Drug delivery system: targeting of pentamidines to specific sites using sugar grafted liposomes”J. Antimicrob. Chemother. 38:145-150 (1996).
Bursen et al., “Interaction of AF4 wild-type and AF4 • MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?”Oncogene23:6237-6249 (2004).
Byrom et al., “Inducing RNAi with siRNA Cocktails Generated by RNase III”TechNotes 10(1), Ambion [online], www.ambion.com/techlib/tn/101/4.html (2003).
Caslini et al., “Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein”Leukemia18:1064-1071 (2004).
Cevc et al., “Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin”Biochim. Biophys. Acta1368:201-215 (1998).
Cheng et al., “RNA interference and human disease”Mol. Genet. Metab. 80:121-128 (2003).
Collins et al., “Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture”Nature270:347-349 (1977).
Domer et al., “Acute mixed-lineage leukemia t(4;11)(q21;a23) generates anMLL-AF4fusion product”Proc. Natl. Acad. Sci. USA 90:7884-7888 (1993).
Dörrie et al., “Regulation of CD95 expression and CD95-mediated cell death by interferon-γ in acute lymphoblastic leukemia with chromosomal translocation t(4;11)”Leukemia13:1539-1547 (1999).
Downing et al., “The der(11)-Encoded MLL/AF-4 Fusion Transcript Is Consistently Detected in t(4;11)(q21;q23)-Containing Acute Lymphoblastic Leukemia”Blood83:330-335 (1994).
Dunne et al., “The Apparent Uptake of Fluorescently Labeled siRNAs by Electroporated Cells Depends on the Fluorochrome”Oligonucleotides13:375-380 (2003).
Dykxhoorn et al., “Killing the messenger: short RNAs that silence gene expression”Nat. Rev. Mol. Cell Biol. 4:457-467 (2003).
Elbashir et al., “Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells”Nature411:494-498 (2001).
Elbashir et al., “RNA interference is mediated by 21- and 22-nucleotide RNAs”Genes Dev. 15:188-200 (2001).
Ernst et al., “The role ofMLLin hematopoiesis and leukemia”Curr. Opin. Hematol. 9:282-287 (2002).
Foldvari et al., “Clinical observations with topical liposome-encapsulated inteferon alpha for the treatment of genital papillomavirus infections”J. Liposome Res. 7:115-126 (1997).
Foldvari et al., “Liposome encapsulated prostaglandin E1in erectile dysfunction: correlation between in vitro delivery through foreskin and efficacy in patients”Urology52:838-843 (1998).
GenBank Accession No. D13979, “Homo sapiens mRNA for AML1-MTG8 fusion protein, complete cds” May 29, 2002.
GenBank Accession No. L11017, “Transponson Tn5Tac1 (fromE coli) DNA sequence” Jun. 20, 2002.
GenBank Accession No. L22179, “Human MLL-AF4 der(11) fusion protein mRNA, complete cds” Sep. 15, 1993.
GenBank Accession No. M15077, “P.pyralis(firefly) luciferase gene, complete cds” Apr. 26, 1993.
Greil et al., “Suppression of MLL-AF4 by Small Interfering RNAs Inhibits Proliferation and Induces Apoptosis in T(4;11)-Positive SEM Cells”Blood104:191b, Abstract No. 4433 (2004).
Greil et al., “The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7”Br. J. Haematol. 86:275-283 (1994).
Gu et al., “The t(4;11) Chromosome Translocation of Human Acute Leukemias Fuses theALL-1Gene, Related toDrosophila trithorax, to theAF-4Gene”Cell71:701-708 (1992).
Heidenreich, “Oncogene Suppression by Small Interfering RNAs”Curr. Pharm. Biotechnol. 5:349-354 (2004).
Heidenreich et al., “AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells”Blood101:3157-3163 (2003).
Ho et al., “Interactions of Target-sensitive Immunoliposomes with Herpes Simplex Virus”J. Biol. Chem. 262:13797-13984 (1987).
Ho et al., “Target-sensitive Immunoliposomes as an Efficient Drug Carrier for Antiviral Activity”J. Biol. Chem. 262:13973-13978 (1987).
Hsieh et al., “Proteolytic Cleavage of MLL Generates a Complex of N- and C-Terminal Fragments That Confers Protein Stability and Subnuclear Localization”Mol. Cell. Biol. 23:186-194 (2003).
Hsieh et al., “Taspase1: A Threonine Aspartase Required for Cleavage of MLL and ProperHOXGene Expression”Cell115:293-303 (2003).
Isnard et al., “Altered lymphoid development in mice deficient for the mAF4 proto-oncogene”Blood96:705-710 (2000).
Kersey et al., “Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for the extensive extamedullary accumulation of cells and poor prognosis”Leukemia12:1561-1564 (1998).
Khvorova et al., “Functional siRNAs and miRNAs Exhibit Strand Bias”Cell115:209-216 (2003).
Klibanov et al., “Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes”FEBS Lett. 268:235-237 (1990).
Lange et al., “Biological Markers in Urologic Cancer”Cancer60:464-472 (1987).
Li et al., “AF4 Encodes a Ubiquitous Protein That in Both Native and MLL-AF4 Fusion Types Localizes to Subnuclear Compartments”Blood92:3841-3847 (1998).
Limbach et al., “Summary: the modified nuclesides of RNA”Nucleic Acids Res. 22:2183-2196 (1994).
Lozzio et al., “Brief Communication: Cytotoxicity of a Factor Isolated From Human Spleen”J. Natl. Cancer Inst. 50:535-538 (1973).
Marschalek et al., “Molecular analysis of the chromosomal breakpoint and fusion transcripts in the acute lymphoblastic SEM cell line with chromosomal translocation t(4;11)”Br. J. Haematol. 90:308-320 (1995).
Martinez et al., “The oncogenic fusion protein RUNX1-CBFA2T1 supports proliferation and inhibits senescence in t(8;21)-positive leukaemic cells”BMC Cancer4:44 (2004).
Mastrobattista et al., “Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells”Biochim. Biophys. Acta1419:353-363 (1999).
Mastrobattista et al., “Immunoliposomes for the targeted delivery of antitumor drugs”Adv. Drug Deliv. Rev. 40:103-127 (1999).

Affiliated with

Also associated with

Rating

RNAi modulation of MLL-AF4 and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with RNAi modulation of MLL-AF4 and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and RNAi modulation of MLL-AF4 and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3949128